Patents by Inventor Fred Ramsdell
Fred Ramsdell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20110144309Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.Type: ApplicationFiled: November 8, 2010Publication date: June 16, 2011Applicant: Celltech R&D, Inc.Inventors: Fred Ramsdell, Sean C. Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
-
Patent number: 7850968Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.Type: GrantFiled: October 2, 2009Date of Patent: December 14, 2010Assignee: Celltech R&D LimitedInventors: Fred Ramsdell, Sean C Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
-
Publication number: 20100081797Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.Type: ApplicationFiled: October 2, 2009Publication date: April 1, 2010Applicant: CELLTECH R&D, INC.Inventors: Fred Ramsdell, Sean C. Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
-
Patent number: 7618629Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.Type: GrantFiled: November 21, 2002Date of Patent: November 17, 2009Assignee: Celltech R&D, Inc.Inventors: Fred Ramsdell, Sean C. Proll, Karen Staehling-Hampton, Mark W. Appleby, Leon Fernando Garcia-Martinez
-
Publication number: 20090169543Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin and proteins that induce or inhibit Foxp3 expression.Type: ApplicationFiled: November 6, 2008Publication date: July 2, 2009Applicant: UCB SAInventors: Roli Khattri, Mary E. Brunkow, Fred Ramsdell
-
Patent number: 7507542Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin (Fkhsf) and proteins that induce or inhibit Scurfin or Foxp3 expression.Type: GrantFiled: May 8, 2002Date of Patent: March 24, 2009Assignee: UCB SAInventors: Roli Khattri, Mary E Brunkow, Fred Ramsdell
-
Publication number: 20080131411Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: ApplicationFiled: April 16, 2007Publication date: June 5, 2008Applicant: UCB SAInventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Patent number: 7220579Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: GrantFiled: November 15, 2004Date of Patent: May 22, 2007Assignee: UCB SAInventors: Mary E Brunkow, Eric W Jeffery, Kathryn A Hjerrild, Fred Ramsdell
-
Patent number: 7135612Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: GrantFiled: September 3, 2004Date of Patent: November 14, 2006Assignee: UCB SAInventors: Mary E Brunkow, Eric W Jeffery, Kathryn A Hjerrild, Fred Ramsdell
-
Publication number: 20060083740Abstract: The invention provides methods for modulating cytokine levels, GM-CSF levels and the immune system using CD83 nucleic acids, CD83 polypeptides, anti-CD83 antibodies and factors that influence CD83 activity or expression. The invention also provides mice having a mutant CD83 gene and mice having a transgenic CD83 gene, which are useful for defining the role of CD83 in the immune system and for identifying compounds that can modulate CD83 and the immune system.Type: ApplicationFiled: November 21, 2002Publication date: April 20, 2006Applicant: Celltech R&D, Inc.Inventors: Fred Ramsdell, Sean Proll, Karen Staehling-Hampton, Mark Appleby, Leon Garcia-Martinez
-
Publication number: 20050164247Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: ApplicationFiled: November 15, 2004Publication date: July 28, 2005Applicant: Celltech R & D LimitedInventors: Mary Brunkow, Eric Jeffery, Kathryn Hjerrild, Fred Ramsdell
-
Publication number: 20050106601Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: ApplicationFiled: September 3, 2004Publication date: May 19, 2005Applicant: Celltech R & D LimitedInventors: Mary Brunkow, Eric Jeffery, Kathryn Hjerrild, Fred Ramsdell
-
Patent number: 6884618Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: GrantFiled: April 2, 2002Date of Patent: April 26, 2005Assignee: Darwin Discovery Ltd.Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Patent number: 6794145Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: GrantFiled: October 24, 2000Date of Patent: September 21, 2004Assignee: Darwin Discovery Ltd.Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Patent number: 6683171Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: GrantFiled: October 25, 2000Date of Patent: January 27, 2004Assignee: Darwin Discovery Ltd.Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Patent number: 6683160Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Assays that are based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), may be used for identifying numerous molecules that modulate the immune system. Molecules that specifically bind to an Fkhsf polypeptide are also provided as useful, such as, for modulating the biological activities of Fkhsf. In particular, antibodies that are specific for Fkhsf polypeptide are provided for uses such as for detecting the expression of an Fkhsf polypeptide in cells, isolating an Fkhsf polypeptide, and modulating the activity of an Fkhsf polypeptide.Type: GrantFiled: October 25, 2000Date of Patent: January 27, 2004Assignee: Darwin Discovery LimitedInventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Patent number: 6667162Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Utilizing assays based upon the nucleic acid sequences disclosed herein (as well as mutant forms thereof), numerous molecules may be identified which modulate the immune system.Type: GrantFiled: October 25, 2000Date of Patent: December 23, 2003Assignee: Darwin Discovery LimitedInventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Publication number: 20030170648Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin and proteins that induce or inhibit Foxp3 expression.Type: ApplicationFiled: May 8, 2002Publication date: September 11, 2003Applicant: Darwin Molecular CorporationInventors: Roli Khattri, Mary E. Brunkow, Fred Ramsdell
-
Publication number: 20020168736Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors.Type: ApplicationFiled: April 2, 2002Publication date: November 14, 2002Applicant: Darwin Discovery Ltd.Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell
-
Patent number: 6414129Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors.Type: GrantFiled: August 11, 1999Date of Patent: July 2, 2002Assignee: Darwin Discovery Ltd.Inventors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Fred Ramsdell